The Simple Antidote to the Poisonous ‘Race Science’ Revival
By Dan Samorodnitsky,
The Daily Beast
| 06. 12. 2022
On May 14, a gunman walked into a Tops grocery store in a predominantly Black neighborhood in Buffalo, New York. The massacre killed 10 people. Beforehand, he had posted a long screed online about Great Replacement Theory, using, among other things, links to a series of genetics studies—peer reviewed, and published in prestigious journals like Nature—as citations. These were a variety of human behavioral genetics studies, a field of research that tries to use genetics to find the source of complex human behaviors. One study was a genomic study on whether intelligence is inherited from one generation to the next. Another was on the genetics of different psychological traits. Then another study on the genetics of intelligence.
Scientists have been quick to write and denounce the Buffalo shooter. “Scientists have to recognize that their research can be weaponized,” Janet D. Stemwedel, a philosopher of science at San José State University, wrote weeks later in Scientific American. “They need to think hard not only about how their findings might be misinterpreted or misused, but also about the... see more
Related Articles
By Sarah Zhang, The Atlantic | 06.22.2022
Photo by ANIRUDH on Unsplash
In October 2019, Jordan Janz became the first person in the world to receive an experimental therapy for cystinosis, a rare genetic disease. The treatment was physically grueling. Doctors extracted blood stem cells from Janz’s...
By Ian Sample , The Guardian | 06.22.2022
More than half the UK backs the idea of rewriting the DNA of human embryos to prevent severe or life-threatening diseases, according to a survey.
Commissioned by the Progress Educational Trust (PET), a fertility and genomics charity, the Ipsos poll...
By Fiorella Valdesolo, WSJ Magazine | 06.08.2022
“Where is the we?” It’s the question that was the driving force for Vida Delrahim and Ronit Menashe when they created WeNatal, a new brand of prenatal supplements that aims to be more inclusive. In the process of trying...
By Michael Le Page, New Scientist | 06.16.2022
CRISPR gene-editing trials for treating sickle cell disease and beta thalassaemia are being extended to include children aged under 12 after the therapies proved successful in ongoing trials involving people aged between 12 and 35. The aim is to treat...